Cooper Companies (NYSE:COO – Get Rating) had its price objective raised by Robert W. Baird from $385.00 to $400.00 in a research note released on Friday morning, The Fly reports. A number of other research firms have also issued reports on COO. Piper Sandler lifted their price objective on shares of Cooper Companies from $375.00 […]
Picton Mahoney Asset Management boosted its holdings in The Cooper Companies, Inc. (NYSE:COO – Get Rating) by 348.2% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 986 shares of the medical device company’s stock after buying an additional 766 shares during the period. Picton Mahoney Asset Management’s […]
Cooper Companies (NYSE:COO – Get Rating) posted its earnings results on Thursday. The medical device company reported $3.08 earnings per share for the quarter, beating analysts’ consensus estimates of $2.99 by $0.09, Briefing.com reports. Cooper Companies had a return on equity of 8.39% and a net margin of 11.10%. The company had revenue of $877.40 […]
Morgan Stanley initiated coverage on shares of Cooper Companies (NYSE:COO – Get Rating) in a research note released on Tuesday morning, The Fly reports. The brokerage issued an equal weight rating and a $410.00 price objective on the medical device company’s stock. A number of other equities analysts have also recently issued reports on the […]
Cooper Companies (NYSE:COO – Get Rating) issued an update on its FY23 earnings guidance on Thursday morning. The company provided EPS guidance of $12.66-12.96 for the period, compared to the consensus EPS estimate of $12.78. The company issued revenue guidance of $3.512-3.569 billion, compared to the consensus revenue estimate of $3.55 billion. Cooper Companies Price […]